Treatment of Ocular Toxocariasis

Diagnostic Confirmation

• Formal ophthalmologic examination (including dilated fundus inspection) should be performed to detect retinal granuloma, uveitis, vitritis, or vitreous opacity in patients with suspected ocular toxocariasis. 1

Anthelmintic Therapy

• Albendazole 400 mg orally twice daily for 2 weeks is the preferred anthelmintic regimen for ocular toxocariasis. 1

Anti‑inflammatory Management

• Systemic corticosteroids (oral prednisolone 0.5–1 mg/kg/day) must be administered concurrently with albendazole to control intra‑ocular inflammation. 1
• Topical corticosteroid eye drops (dexamethasone 0.1 % twice daily) provide additional local anti‑inflammatory effect and should be used throughout the course of systemic therapy. 1

Integrated Care

• Management should be coordinated with an ophthalmologist throughout the treatment period to monitor ocular response and adjust therapy as needed. 1

Monitoring During Acute Phase

• Patients should undergo daily ophthalmologic review while acute inflammation is present to promptly identify complications and assess treatment response. 1

Safety and Pitfalls

• Antiparasitic medication should never be given without concurrent corticosteroids, as monotherapy can trigger severe inflammatory reactions from dying larvae. 1
• Eosinophilia is less common in cases where toxocariasis presents solely as ocular disease compared with visceral larva migrans; clinicians should not assume the absence of systemic involvement based on normal eosinophil counts. [1][2]

Treatment of Ocular Toxocariasis

Diagnosis and Clinical Presentation

• Ocular toxocariasis presents with visual changes, retinal granuloma, or uveitis, with eosinophilia being less common in isolated ocular disease 3

Treatment Algorithm

• The recommended treatment for ocular toxocariasis is albendazole 400 mg twice daily for 2 weeks combined with corticosteroids, with joint management by an ophthalmologist 3
• Corticosteroid therapy should be administered to control inflammation 3
• Joint management with ophthalmology is essential for optimal outcomes 3

Advanced or Complicated Cases

• In cases with significant vitreous involvement, intravitreal injections may be considered, similar to management approaches for other ocular parasitic infections 4
• Vitrectomy should be considered in cases with significant vitreous opacity or when fungal/parasitic abscesses are inaccessible to systemic agents 4
• For cases with macular involvement, more aggressive therapy may be required 4

Special Considerations

• Screening for potential co-infections is recommended before initiating prolonged corticosteroid therapy to prevent hyperinfection 3
• Ocular toxocariasis may occur without systemic eosinophilia, making diagnosis challenging 3